Printer Friendly

HEALTHDYNE ANNOUNCES PROPOSED PUBLIC OFFERING OF ITS TECHNOLOGIES SUBSIDIARY

 MARIETTA, Ga., April 7 /PRNewswire/ -- Healthdyne, Inc. (NASDAQ: HDYN) announced today that its subsidiary, Healthdyne Technologies, Inc., filed a registration statement with the Securities and Exchange Commission for an underwritten public offering by Healthdyne Technologies of up to 1.75 million newly issued shares of Technologies' common stock with a price range set forth in the registration statement of $9 to $11 per share.
 The offering is being underwritten by Cowen & Company, Needham & Company, Inc. and Interstate/Johnson Lane Corporation.
 Healthdyne, which has 15.1 million shares of common stock outstanding, will own 7.5 million shares, or 81 percent, of the total 9.25 million shares of Healthdyne Technologies to be outstanding after completion of the offering. At the low end of the price range or $9 per share, Healthdyne's 81 percent ownership in Technologies will have an equivalent stock market value of approximately $4.46 per Healthdyne share. At the upper end of the price range, the stock market value will have an equivalent value equal to $5.45 per Healthdyne share.
 Parker H. Petit, chairman and CEO of Healthdyne, stated: "This offering is the second step of our plan to have each of our three operating subsidiaries separately traded in the public market. Following the offering, both Healthdyne Technologies and Home Nutritional Services will be publicly traded, leaving Healthdyne Perinatal Services as the company's only wholly owned subsidiary."
 A written prospectus describing the offering is expected to be available within 10 days and can be obtained from Cowen & Company, One Financial Square, New York, NY 10005-3594, 212-495-6000, or from either of the other managing underwriters.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold not may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 Healthdyne is a national provider of high technology home health care medical services and products which include home obstetrical care through its Perinatal Services subsidiary, home infusion therapy through its partially owned Home Nutritional Services subsidiary, and high technology health care products through Healthdyne Technologies.
 -0- 4/7/93
 /CONTACT: Donald R. Millard of Healthdyne, 404-423-4529/
 (HDYN)


CO: Healthdyne, Inc.; Healthdyne Technologies, Inc. ST: Georgia IN: MTC SU: OFR

BR-BN -- AT001 -- 3645 04/07/93 07:48 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 7, 1993
Words:443
Previous Article:CONSILIUM DISCLOSES PAYMENTS FROM NEW ALLIANCE
Next Article:F&M DISTRIBUTORS ANNOUNCES FOURTH-QUARTER AND ANNUAL EARNINGS
Topics:


Related Articles
HEALTHDYNE ANNOUNCES SECOND QUARTER RESULTS
HEALTHDYNE ANNOUNCES SALE OF ITS HNS SUBSIDIARY
HEALTHDYNE ANNOUNCES COMPLETION OF $61 MILLION SALE OF INTEREST IN HNS
HEALTHDYNE ANNOUNCES SECOND QUARTER RESULTS AND FORMATION OF NEW SUBSIDIARY
HEALTHDYNE ANNOUNCES THIRD QUARTER RESULTS
HEALTHDYNE ANNOUNCES PROPOSED SPIN-OFF OF HEALTHDYNE TECHNOLOGIES AND 1994 FINANCIAL RESULTS
HEALTHDYNE ANNOUNCES BOARD APPROVAL OF SPIN-OFF OF HEALTHDYNE TECHNOLOGIES
HEALTHDYNE ANNOUNCES FILING OF REGISTRATION STATEMENT TO SPIN-OFF HEALTHDYNE INFORMATION ENTERPRISES
Healthdyne Technologies States Invacare's Press Release Inaccurate
Healthdyne Technologies Announces Record Revenue and Earnings for the Third Quarter

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters